{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:04:58Z","timestamp":1790744698098,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["GHS-A-00-09-00003-00"],"award-info":[{"award-number":["GHS-A-00-09-00003-00"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232966","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T17:31:32Z","timestamp":1594315892000},"page":"e0232966","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Importance of medicine quality in achieving universal health coverage"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-9038","authenticated-orcid":true,"given":"Sachiko","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen R.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatenda T.","family":"Yemeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4093-2606","authenticated-orcid":true,"given":"Jude I.","family":"Nwokike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Hajjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor S.","family":"Pribluda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"pone.0232966.ref001","doi-asserted-by":"crossref","DOI":"10.1596\/31930","volume-title":"What is health financing for universal coverage?","author":"World Health Organization","year":"2019"},{"key":"pone.0232966.ref002","volume-title":"Sustainable development goals (SDGs): Goal 3. Target 3.8","author":"World Health Organization","year":"2019"},{"key":"pone.0232966.ref003","volume-title":"A study on the public health and socioeconomic impact of substandard and falsified medical products","author":"World Health Organization","year":"2017"},{"key":"pone.0232966.ref004","unstructured":"World Health Organization. Seventieth World Health Assembly Update. 29 May. Geneva, Switzerland: World Health Organization, 2017."},{"issue":"4","key":"pone.0232966.ref005","doi-asserted-by":"crossref","first-page":"e181662","DOI":"10.1001\/jamanetworkopen.2018.1662","article-title":"Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis","volume":"1","author":"S Ozawa","year":"2018","journal-title":"JAMA network open"},{"issue":"10","key":"pone.0232966.ref006","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.xphs.2017.05.018","article-title":"Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016","volume":"106","author":"A Koczwara","year":"2017","journal-title":"Journal of pharmaceutical sciences"},{"issue":"2","key":"pone.0232966.ref007","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bcp.12298","article-title":"Substandard drugs: a potential crisis for public health","volume":"78","author":"A Johnston","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"pone.0232966.ref008","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4269\/ajtmh.18-0981","article-title":"Falsified and Substandard Drugs: Stopping the Pandemic","volume":"100","author":"GML Nayyar","year":"2019","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"pone.0232966.ref009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2458-14-63","article-title":"Why the MDGs need good governance in pharmaceutical systems to promote global health","volume":"14","author":"JC Kohler","year":"2014","journal-title":"BMC public health"},{"key":"pone.0232966.ref010","volume-title":"World health report: health systems financing\u2014the path to universal coverage","author":"World Health Organization","year":"2010"},{"issue":"10160","key":"pone.0232966.ref011","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0140-6736(18)31668-4","article-title":"Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries","volume":"392","author":"ME Kruk","year":"2018","journal-title":"The Lancet"},{"key":"pone.0232966.ref012","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1472-6963-14-357","article-title":"Quality use of medicines within universal health coverage: challenges and opportunities","volume":"14","author":"AK Wagner","year":"2014","journal-title":"BMC health services research"},{"issue":"10067","key":"pone.0232966.ref013","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(16)31599-9","article-title":"Essential medicines for universal health coverage","volume":"389","author":"VJ Wirtz","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"pone.0232966.ref014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40545-015-0028-4","article-title":"Medicines and universal health coverage: challenges and opportunities","volume":"8","author":"M Bigdeli","year":"2015","journal-title":"Journal of pharmaceutical policy and practice"},{"issue":"1","key":"pone.0232966.ref015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12913-018-2993-1","article-title":"Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji","volume":"18","author":"Y Huang","year":"2018","journal-title":"BMC health services research"},{"issue":"1","key":"pone.0232966.ref016","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12913-018-2943-y","article-title":"Selling my sheep to pay for medicines\u2014household priorities and coping strategies in a setting without universal health coverage","volume":"18","author":"KH Onarheim","year":"2018","journal-title":"BMC health services research"},{"issue":"suppl 1","key":"pone.0232966.ref017","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/nutrit\/nuw049","article-title":"A systems approach to obesity","volume":"75","author":"BY Lee","year":"2017","journal-title":"Nutrition reviews"},{"issue":"Suppl 7","key":"pone.0232966.ref018","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1186\/s12913-016-1867-7","article-title":"Exploring pathways for building trust in vaccination and strengthening health system resilience","volume":"16","author":"S Ozawa","year":"2016","journal-title":"BMC health services research"},{"issue":"1","key":"pone.0232966.ref019","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vaccine.2016.11.025","article-title":"Map of different vaccine supply chain efficiency measures","volume":"35","author":"LA Haidari","year":"2017","journal-title":"Vaccine"},{"issue":"Suppl 1Suppl 1","key":"pone.0232966.ref020","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1016\/j.vaccine.2016.11.033","article-title":"A systems approach to vaccine decision making","volume":"35","author":"BY Lee","year":"2017","journal-title":"Vaccine"},{"key":"pone.0232966.ref021","unstructured":"UHC2030. UHC indicators for SDG monitoring framework agreed 2017 [cited 2019 March 1]. Available from: https:\/\/www.uhc2030.org\/news-events\/uhc2030-news\/uhc-indicators-for-sdg-monitoring-framework-agreed-398330\/."},{"key":"pone.0232966.ref022","unstructured":"World Health Organization. UHC service coverage. Geneva, Switzerland: World Health Organization; 2015 [cited 2020 April 27]. Available from: https:\/\/apps.who.int\/gho\/data\/view.main.INDEXOFESSENTIALSERVICECOVERAGEv?lang=en."},{"key":"pone.0232966.ref023","volume-title":"World Governance Indicators","author":"World Bank","year":"2018"},{"key":"pone.0232966.ref024","unstructured":"United States Agency for International Development. The Journey To Self-Reliance Country Roadmaps 2019 [cited 2019 May 24]. Available from: https:\/\/selfreliance.usaid.gov\/."},{"key":"pone.0232966.ref025","unstructured":"United Nations Children's Fund (UNICEF). Child Mortality Estimates New York: UNICEF; 2019 [cited 2019 January 15]. Available from: https:\/\/data.unicef.org\/topic\/child-survival\/under-five-mortality\/."},{"issue":"1","key":"pone.0232966.ref026","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12936-018-2628-3","article-title":"Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study","volume":"18","author":"S Ozawa","year":"2019","journal-title":"Malaria journal"},{"issue":"5","key":"pone.0232966.ref027","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4269\/ajtmh.18-0334","article-title":"Modeling the Economic Impact of Substandard and Falsified Antimalarials in the Democratic Republic of the Congo","volume":"100","author":"S Ozawa","year":"2019","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"8","key":"pone.0232966.ref028","doi-asserted-by":"crossref","first-page":"e0217910","DOI":"10.1371\/journal.pone.0217910","article-title":"The economic impact of substandard and falsified antimalarial medications in Nigeria","volume":"14","author":"SM Beargie","year":"2019","journal-title":"PloS one"},{"key":"pone.0232966.ref029","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12936-016-1357-8","article-title":"Combating poor-quality anti-malarial medicines: a call to action","volume":"15","author":"Q Bassat","year":"2016","journal-title":"Malaria journal"},{"issue":"2","key":"pone.0232966.ref030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2471\/BLT.17.199562","article-title":"Medicines quality assurance to fight antimicrobial resistance","volume":"96","author":"J Nwokike","year":"2018","journal-title":"Bulletin of the World Health Organization"},{"key":"pone.0232966.ref031","volume-title":"Medicines in health systems: advancing access, affordability and appropriate use","author":"World Health Organization","year":"2014"},{"key":"pone.0232966.ref032","unstructured":"World Health Organization, Organisation for Economic Co-operation and Development, The World Bank. Delivering quality health services: a global imperative for universal health coverage Geneva, Switzerland. 2018 [cited 2019 July 23]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272465\/9789241513906-eng.pdf?ua=1."},{"issue":"8","key":"pone.0232966.ref033","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1377\/hlthaff.2015.1043","article-title":"Combined Regional Investments Could Substantially Enhance Health System Performance And Be Financially Affordable","volume":"35","author":"J Homer","year":"2016","journal-title":"Health Affairs"},{"key":"pone.0232966.ref034","volume-title":"Strengthening Regulatory Systems To Improve Medical Product Quality in Low- and Middle-Income Countries","author":"G Kaddu","year":"2018"},{"key":"pone.0232966.ref035","volume-title":"Regulatory system strengthening","author":"World Health Organization","year":"2019"},{"key":"pone.0232966.ref036","volume-title":"Good Manufacturing Practices","author":"World Health Organization","year":"2019"},{"issue":"5","key":"pone.0232966.ref037","doi-asserted-by":"crossref","first-page":"e0217334","DOI":"10.1371\/journal.pone.0217334","article-title":"The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data","volume":"14","author":"WA Kaplan","year":"2019","journal-title":"PloS one"},{"issue":"1","key":"pone.0232966.ref038","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0163-7258(94)90004-3","article-title":"Bioequivalence requirements for generic products. Pharmacology &","volume":"62","author":"RL Nation","year":"1994","journal-title":"Therapeutics"},{"issue":"5","key":"pone.0232966.ref039","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jval.2012.04.004","article-title":"Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?","volume":"15","author":"A Cameron","year":"2012","journal-title":"Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"issue":"3","key":"pone.0232966.ref040","doi-asserted-by":"crossref","first-page":"e1001802","DOI":"10.1371\/journal.pmed.1001802","article-title":"Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States","volume":"12","author":"A Sarpatwari","year":"2015","journal-title":"PLOS Medicine"},{"key":"pone.0232966.ref041","volume-title":"Estimating Cost Savings From Generic Drug Approvals In 2017","author":"R Conrad","year":"2017"},{"issue":"6","key":"pone.0232966.ref042","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jsps.2013.12.017","article-title":"The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use","volume":"22","author":"MA Hassali","year":"2014","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"6","key":"pone.0232966.ref043","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14787210.2016.1187560","article-title":"A link between poor quality antimalarials and malaria drug resistance?","volume":"14","author":"PN Newton","year":"2016","journal-title":"Expert review of anti-infective therapy"},{"issue":"Supplement_3","key":"pone.0232966.ref044","doi-asserted-by":"crossref","first-page":"iii36","DOI":"10.1093\/heapol\/czz012","article-title":"Poor-quality antimalarials further health inequalities in Uganda","volume":"34","author":"DR Evans","year":"2019","journal-title":"Health Policy and Planning"},{"issue":"10004","key":"pone.0232966.ref045","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0140-6736(15)00514-0","article-title":"Essential medicines are still essential","volume":"386","author":"AL Gray","year":"2015","journal-title":"Lancet"},{"issue":"10163","key":"pone.0232966.ref046","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/S0140-6736(18)32986-6","article-title":"A global accountability mechanism for access to essential medicines","volume":"392","author":"M Simao","year":"2018","journal-title":"Lancet"},{"key":"pone.0232966.ref047","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fphar.2017.00751","article-title":"Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study","volume":"8","author":"JC Meyer","year":"2017","journal-title":"Frontiers in pharmacology"},{"key":"pone.0232966.ref048","first-page":"2050312115596864","article-title":"Quality use of medicine in a developing economy: Measures to overcome challenges in the Malaysian healthcare system","volume":"3","author":"NA Mohd-Tahir","year":"2015","journal-title":"SAGE open medicine"},{"key":"pone.0232966.ref049","doi-asserted-by":"crossref","first-page":"l5327","DOI":"10.1136\/bmj.l5327","article-title":"How moves towards universal health coverage could encourage poor quality drugs: an essay by Elizabeth Pisani","volume":"366","author":"E Pisani","year":"2019","journal-title":"BMJ"},{"issue":"70","key":"pone.0232966.ref050","article-title":"Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania","volume":"4","author":"E Pisani","year":"2019","journal-title":"Wellcome Open Research"},{"key":"pone.0232966.ref051","doi-asserted-by":"crossref","first-page":"l6004","DOI":"10.1136\/bmj.l6004","article-title":"Universal health coverage: drug quality and affordability can go together","volume":"367","author":"R Ravinetto","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"pone.0232966.ref052","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1057\/jphp.2013.53","article-title":"A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme","volume":"35","author":"EF t Hoen","year":"2014","journal-title":"Journal of public health policy"},{"issue":"8","key":"pone.0232966.ref053","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2471\/BLT.18.229179","article-title":"Patent pooling to increase access to essential medicines","volume":"97","author":"E Burrone","year":"2019","journal-title":"Bulletin of the World Health Organization"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T17:32:03Z","timestamp":1594315923000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232966"}},"subtitle":[],"editor":[{"given":"Lutz","family":"Heide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232966","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]}}}